Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.160
+0.030 (1.41%)
Dec 20, 2024, 4:00 PM EST - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $15.11 million as of December 20, 2024. Its market cap has decreased by -63.78% in one year.
Market Cap
15.11M
Enterprise Value
48.58M
1-Year Change
-63.78%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $15.11M, a decrease of -86.34%. That is a compound annual growth rate of -17.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 15.10M | -64.88% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nephros | 16.24M |
| Unity Biotechnology | 16.17M |
| The Oncology Institute | 15.87M |
| bioAffinity Technologies | 15.47M |
| Traws Pharma | 15.19M |
| GlycoMimetics | 15.08M |
| BioXcel Therapeutics | 14.58M |
| ProPhase Labs | 14.58M |